The first and only publication designed to aid investigators in identifying new drug study opportunities. Published monthly, each 28 - 40 page issue includes timely, concise articles about which compounds companies are targeting for which indications, where they stand in their research, when they plan to begin clinical trials and how you can contact them.  Within each medical specialty, items are arranged by stage of development from drugs in preclinical testing to Phase I - III trials, FDA approvals and post-approval studies. Every issue of CLINICAL INVESTIGATOR NEWS is indexed by drug, disease and organization, and includes the names, addresses and phone and fax numbers of key contacts.

This daily electronic newsletter updates the highly competitive pharmaceutical and biotechnology industries.  Every business day, you'll receive concise summaries of  4-8 business and product development news stories.  Be first to know what your competitors are doing and what business opportunities are emerging.  With each up-to-the-minute story, our editorial staff includes a key contact name, as well as phone and fax numbers, so you can reach the person who can supply you with details.  You will receive PHARMACEUTICAL NEWS DAILY first thing in the morning via E-mail.

If you're interested in

This monthly four-page newsletter summarizes the changes in the drug development plans
of  U.S. and Canadian pharmaceutical companies.  Each issue alerts you to more than 120 products that are moving through the pipeline.  Learn what the competition is up to, how far along they are in developing drugs for certain indications and what their future plans are -- all arranged in convenient table format.